Cytokine involved in epithelial-mesenchymal transition
CA 2537473 C · Owner: Tamir, Ido · Inventors: Jung, Birgit; Seither, Peter; Jechlinger, Martin
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The functional characterization of ILEI to be a cytokine involved in epithelial/mesenchymal transition and the identification of biologically active ILEI provides the basis for generating ILEI inhibitors in particular , anti-ILEI antibodies, that are useful in the therapy of cancer fibrosis and , COPD.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 2, 2004 and granted February 10, 2015. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 2, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 2, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.